| http://www.w3.org/ns/prov#value | - Desoxypipradrol was developed by the pharmaceutical company CIBA (now called Novartis) in the 1950s,[3] and researched for applications such as the treatment of narcolepsy and ADHD; however, it was dropped from development after the related drug methylphenidate was developed by the same company.
|
